2016
DOI: 10.1177/1849543516673445
|View full text |Cite
|
Sign up to set email alerts
|

Development, in vitro and in vivo evaluations of novel lipid drug delivery system of Newbouldia laevis (P. Beauv.)

Abstract: Newbouldia laevis (P. Beauv.) is a tropical rainforest plant used in traditional folk medicine for the treatment of malaria, cough, joint pains, stomach ache, oedema and inflammation. The main thrust of this research work was to study the analgesic/anti-nociceptive properties of N. laevis-loaded solid lipid microdispersions. N. laevis leaves were extracted using ethanol, and the extract was formulated into solid lipid microdispersions using lipid matrix comprising a rational blend of Precirol® ATO 5 and Softis… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 23 publications
0
1
0
Order By: Relevance
“…The DSC thermograms and the endothermic events of the main raw materials used to formulate the LNs, as well as the extract, are shown in Figure 8 . The results demonstrate that the melting enthalpy decreased sharply when comparing the primary lipid and the LNs [ 66 , 67 ]. This decrease in enthalpy indicates a decrease in the lipid matrix crystallinity, and it is commonly reported in works on the production of nanocarriers with crystalline structures, such as lipid nanoparticles [ 68 , 69 ].…”
Section: Discussionmentioning
confidence: 99%
“…The DSC thermograms and the endothermic events of the main raw materials used to formulate the LNs, as well as the extract, are shown in Figure 8 . The results demonstrate that the melting enthalpy decreased sharply when comparing the primary lipid and the LNs [ 66 , 67 ]. This decrease in enthalpy indicates a decrease in the lipid matrix crystallinity, and it is commonly reported in works on the production of nanocarriers with crystalline structures, such as lipid nanoparticles [ 68 , 69 ].…”
Section: Discussionmentioning
confidence: 99%